Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)
Clinical trial NCT02140463 · COMPLETED
Trial details
- NCT number
- NCT02140463
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-02-01
- Primary completion
- 2019-07-01
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.